Skip to main content

Advertisement

Log in

Rare Occurrence of 3 “H”: Hypercalcemia, Hemolytic Anemia and Hodgkin’s Lymphoma

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Clinicians in hematology practice commonly encounter anemia, hypercalcemia and renal failure, which when present in combination evoke a diagnostic workup for multiple myeloma. We report a 71-years old lady who presented to our hematology clinic with fever and easy fatiguability of 3 months duration and on investigations was found to have anemia and hypercalcemia. Direct Coomb’s test characterized the anemia as complement mediated (anti-C3d) hemolysis. Biochemical investigations revealed normal 25(OH) Vitamin D3 and suppressed Parathormone levels and a negative workup for plasma cell dyscrasias, sarcoidosis and autoimmune disorders. CT scan revealed a paravertebral mass with cervical, supraclavicular and abdominal lymphadenopathy along with splenomegaly and left pleural effusion. Biopsy from the paravertebral mass confirmed the diagnosis of Hodgkin’s disease (nodular sclerosis) using immunohistochemistry. Bone marrow examination suggested infiltration by lymphoma. Hypercalcemia was managed with saline and zoledronic acid. Administration of prednisolone (1 mg/kg/day) along with chemotherapy (ABVD regimen) led to normalization of calcium and hemoglobin levels. However, hemolysis recurred 2 weeks later and hence, Rituximab (375 mg/m2) was administered on a weekly schedule for 4 doses and ABVD (2 weekly) was continued, which brought hemolysis under control. Co-occurrence of two paraneoplastic manifestations (complement mediated hemolytic anemia and hypercalcemia) in Hodgkin’s lymphoma is very unusual. Present report aims not only to highlight a rare presentation of Hodgkin’s lymphoma but also focus on the role of Rituximab in controlling hemolysis associated with this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Eisner E, Ley AB, Mayer K (1967) Coomb’s-positive hemolytic anemia in Hodgkin’s disease. Ann Intern Med 66:258–273

    Article  CAS  PubMed  Google Scholar 

  2. Linde R, Basso L (1987) Hodgkin’s disease with hypercalcemia detected by thallium-201 scintigraphy. J Nucl Med 28:112–115

    CAS  PubMed  Google Scholar 

  3. Levine AM, Thornton P, Forman SJ, Van Hale P, Holdorf D, Rouault CL, Powars D et al (1980) Positive Coombs test in Hodgkin’s disease: significance and implications. Blood 55:607–611

    CAS  PubMed  Google Scholar 

  4. Seymour JF, Gagel RF (1993) Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin’s disease and non Hodgkin’s lymphomas. Blood 82:1383–1394

    CAS  PubMed  Google Scholar 

  5. Giannopoulos P, Bergsagel DE (1959) The mechanism of the anemia associated with Hodgkin’s disease. Blood 14:856–869

    CAS  PubMed  Google Scholar 

  6. Gellhorn A, Plimpton CH (1956) Hypercalcemia in malignant disease without evidence of bone destruction. Am J Med 21:750–759

    Article  CAS  PubMed  Google Scholar 

  7. Karmali R, Barker S, Hewison M, Fraher L, Katz DR, O’Riordan JL (1990) Intermittent hypercalcemia and vitamin D sensitivity in Hodgkin’s disease. Postgrad Med J 66:757–760

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Adams JS (1989) Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin N Am 18:765–778

    CAS  Google Scholar 

  9. Krakauer T, Oppenhaim JJ (1993) IL-1 and tumor necrosis factor α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J Immunol 150:1205–1211

    CAS  PubMed  Google Scholar 

  10. Adams ND, Gray RW, Lemann J Jr, Cheung HS (1982) Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21:90–97

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pankaj Malhotra.

Ethics declarations

Conflicts of interest

The authors declare no conflicts of interests.

Ethical statement

The authors declare that the manuscript submitted is in accordance with the ethical guidelines as under Helsinki Declaration 1976.

Consent for publication

The authors hereby declare that appropriate written and informed consent was obtained from the patient prior to publication of any material.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jain, A., Malhotra, P., Prakash, G. et al. Rare Occurrence of 3 “H”: Hypercalcemia, Hemolytic Anemia and Hodgkin’s Lymphoma. Indian J Hematol Blood Transfus 32 (Suppl 1), 163–167 (2016). https://doi.org/10.1007/s12288-016-0672-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-016-0672-0

Keywords

Navigation